Physician

Mark E Tafoya, MD

According to 2025 Medicare claims, Mark Tafoya, MD (NPI: 1639233448) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is PACIFIC RETINA CARE. LLC (NPI: 1619118825; TIN: 263877479) and primary practice location at 96797-5677.

Tafoya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 556 traditional Medicare patients, billed 8,907 HCPCS/CPT codes, and received $519,686 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,400 prescription claims across 389 beneficiaries totaling $427,972 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 12 records totaling $843. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $88,096 to $427,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$262K$524K2015 Medicare payment: $482,420 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $456,260 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $524,365 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $517,936 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $445,998 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $375,230 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $444,046 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $413,180 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $317,780 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $519,686 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153664,744$482,420
20164125,144$456,260
20174345,144$524,365
20184745,113$517,936
20195075,295$445,998
20204593,355$375,230
20215243,832$444,046
20225293,743$413,180
20235013,919$317,780
20245568,907$519,686

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$334K$667K2015 Drug cost: $88,096 (USD; Tot_Drug_Cst)2016 Drug cost: $139,491 (USD; Tot_Drug_Cst)2017 Drug cost: $173,186 (USD; Tot_Drug_Cst)2018 Drug cost: $232,231 (USD; Tot_Drug_Cst)2019 Drug cost: $400,929 (USD; Tot_Drug_Cst)2020 Drug cost: $411,590 (USD; Tot_Drug_Cst)2021 Drug cost: $546,015 (USD; Tot_Drug_Cst)2022 Drug cost: $560,369 (USD; Tot_Drug_Cst)2023 Drug cost: $667,325 (USD; Tot_Drug_Cst)2024 Drug cost: $427,972 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015206903$88,096
20162281,119$139,491
20172671,413$173,186
20182751,452$232,231
20192941,641$400,929
20202921,681$411,590
20213471,851$546,015
20223761,981$560,369
20233702,234$667,325
20243892,400$427,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8282$127
92014Established patient complete exam of visual system481805$86
92134Imaging of retina195530$31
92250Photography of the retina518697$27
92201Extended exam of the back part of the eye with retinal drawing161373$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept401,262$102,552
ProlensaBromfenac Sodium2388,436$86,742
RocklatanNetarsudil Mesylat/Latanoprost712,808$43,188
VabysmoFaricimab-Svoa14392$39,259
Bromfenac SodiumBromfenac Sodium1354,984$27,944

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$843Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark E. Tafoya, MD?

Tedicare shows public-source Medicare data for Mark E. Tafoya, MD (NPI 1639233448), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark E. Tafoya, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark E. Tafoya, MD?

Mark E. Tafoya, MD is linked to PACIFIC RETINA CARE. LLC (billing NPI 1619118825) in the available physician profile data.

Does Mark E. Tafoya, MD have Open Payments data?

Mark E. Tafoya, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.